Help us: Donate
Follow us on:
×

Month: October 2017

Serge Faguet is a Russian entrepreneur, the owner of a profitable travel company, Ostrovok, and the founder of several tech startups, including a new secret, AI-related one in Silicon Valley. For the last few weeks, his name has been all over the internet because of the article “I’m 32 and spent $200k on biohacking. Became...
In recent articles, we have talked about the potential of the immune system to help repair tissue, including for peripheral nerve damage, Atherosclerosis, and Parkinson’s. Immune cells not only fight infection; as this new study shows, they also help the nervous system remove debris, paving the way for nerve regeneration following injury. While previous studies...
In these six years I’ve spent as a rejuvenation advocate, I’ve had to deal with the traditional objections raised against the idea of longer lifespans. These objections touch a variety of different topics, but they aren’t terribly many: we’re talking about maybe a dozen of them, and these days, I hardly ever hear an objection...
Recently, we have explored the benefits that rejuvenation biotechnologies promise to bring to ourselves and the people close to us. I would imagine that most people have no difficulty acknowledging these benefits, but even so, many people tend to focus on potential large-scale downsides of rejuvenation while neglecting entirely its benefits on society at large....
We have been hard at work advocating, writing and supporting the development of life extension technologies, or as we call them, rejuvenation biotechnologies. During the course of our activities, we have found that many people new to the topic have lots of questions and are naturally curious about the science behind it. As great as...
There has been an increase in the level of interest in the field of rejuvenation biotechnology over the last few years. The recent entry of senolytic therapies that clear senescent cells from the body into human clinical trials have spurred even more interest in the field of late. Today we wanted to highlight three very...

Want the latest longevity news? Subscribe to our Newsletter!